OSCR - Oscar Health, Inc.
NYSE
->
Healthcare
->
Healthcare Plans
New York,
United States
Type: Equity
OSCR price evolution
OSCR
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1870.32 | $1399.79 | $2322.07 | $2109.57 |
| Short term investments | $689.83 | $1044.44 | $1255.7 | $1324.54 |
| Net receivables | $494.39 | $539.03 | $607.3 | $686.39 |
| Inventory | ||||
| Total current assets | $3061.1 | $2991.62 | $4192.63 | $4131.22 |
| Long term investments | $395.18 | $206.97 | $216.93 | $192.53 |
| Property, plant & equipment | $61.93 | $62.02 | $63.05 | $64.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $540.38 | $357.89 | $372.31 | $351.81 |
| Total investments | $1085.01 | $1251.41 | $1472.63 | $1517.07 |
| Total assets | $3601.48 | $3349.51 | $4564.94 | $4483.03 |
| Current liabilities | ||||
| Accounts payable | $2357.32 | $1989.1 | $3167.86 | $3104.15 |
| Deferred revenue | $65.92 | $71.6 | $73.07 | $73.35 |
| Short long term debt | ||||
| Total current liabilities | $2429.01 | $2060.88 | $3244.32 | $3181.7 |
| Long term debt | $298.78 | $298.58 | $298.39 | $298.19 |
| Total noncurrent liabilities | $366.35 | $367.2 | $368.66 | $369.57 |
| Total debt | $298.78 | $298.58 | $298.39 | $298.19 |
| Total liabilities | $2795.36 | $2428.08 | $3612.98 | $3551.27 |
| Shareholders' equity | ||||
| Retained earnings | -$2876.72 | -$2726.68 | -$2661.29 | -$2645.76 |
| Other shareholder equity | $1.31 | -$4.45 | -$6.86 | -$4.48 |
| Total shareholder equity | $803.97 | $919.48 | $949.7 | $929.6 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1870.32 | $1558.6 | $1103.99 | $826.33 |
| Short term investments | $689.83 | $1397.29 | $587.09 | $366.39 |
| Net receivables | $494.39 | $49.86 | $611.06 | $675.87 |
| Inventory | ||||
| Total current assets | $3061.1 | $49.86 | $2305.93 | $1870.45 |
| Long term investments | $395.18 | $250.4 | $872.56 | $325.74 |
| Property, plant & equipment | $61.93 | $127.89 | $46.61 | $35.81 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $540.38 | $405.05 | $1015.72 | $401.66 |
| Total investments | $1085.01 | $1647.69 | $1459.65 | $692.13 |
| Total assets | $3601.48 | $4526.6 | $3321.65 | $2272.11 |
| Current liabilities | ||||
| Accounts payable | $2357.32 | $285.02 | $1748 | $1509.12 |
| Deferred revenue | $65.92 | $79 | $75.04 | $71.9 |
| Short long term debt | ||||
| Total current liabilities | $2429.01 | $370.02 | $1852.29 | $1665.6 |
| Long term debt | $298.78 | $298 | $142.49 | |
| Total noncurrent liabilities | $366.35 | $370.28 | $76.84 | $157.49 |
| Total debt | $298.78 | $298 | $142.49 | |
| Total liabilities | $2795.36 | $3636.22 | $1929.13 | $1823.09 |
| Shareholders' equity | ||||
| Retained earnings | -$2876.72 | -$2605.99 | -$1999.71 | -$1427.11 |
| Other shareholder equity | $1.31 | -$9.71 | -$3.67 | $0.88 |
| Total shareholder equity | $803.97 | $890.38 | $1387.23 | -$1295.89 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1439.99 | $1521.54 | $1469.68 | |
| Cost of revenue | $1352.86 | $1378.96 | $1319.01 | |
| Gross Profit | $87.14 | $142.57 | $150.68 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $75.5 | $76.45 | $102.15 | |
| Total operating expenses | $145.38 | $149.1 | $176.04 | |
| Operating income | -$58.24 | -$6.53 | -$25.36 | |
| Income from continuing operations | ||||
| EBIT | -$58.35 | -$8.24 | -$31.61 | |
| Income tax expense | $0.92 | $1.16 | $2.02 | |
| Interest expense | $6.13 | $6.12 | $6.14 | |
| Net income | ||||
| Net income | -$65.4 | -$15.53 | -$39.77 | |
| Income (for common shares) | -$65.4 | -$15.53 | -$39.77 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5862.87 | $462.8 | ||
| Cost of revenue | $5468.04 | $381.17 | ||
| Gross Profit | $394.83 | $81.63 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $339.72 | $166.66 | ||
| Total operating expenses | $630.44 | $483.9 | ||
| Operating income | -$235.62 | -$402.27 | ||
| Income from continuing operations | ||||
| EBIT | -$242.83 | -$402.27 | ||
| Income tax expense | $3.29 | $1.04 | ||
| Interest expense | $24.6 | $3.51 | ||
| Net income | ||||
| Net income | -$270.73 | -$406.82 | ||
| Income (for common shares) | -$270.73 | -$406.82 | ||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$150.03 | -$65.4 | -$15.53 | -$39.77 |
| Operating activities | ||||
| Depreciation | $7.74 | $9.19 | $8.82 | $4.94 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $26.14 | $28.77 | $33.28 | $71.49 |
| Total cash flows from operations | $296.87 | -$1149.27 | $165.52 | $414.71 |
| Investing activities | ||||
| Capital expenditures | -$6.1 | -$6.48 | -$5.62 | -$7.38 |
| Investments | $178.58 | $231.78 | $49.52 | $142.89 |
| Total cash flows from investing | $172.48 | $225.3 | $43.9 | $135.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.07 | $0.3 | $2.55 | $0.04 |
| Net borrowings | ||||
| Total cash flows from financing | $1.07 | $2.32 | $2.55 | $0.51 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $470.41 | -$921.64 | $211.97 | $550.73 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$270.73 | -$606.27 | -$572.61 | -$406.82 |
| Operating activities | ||||
| Depreciation | $30.69 | $15.28 | $14.61 | $11.29 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $159.68 | $112.33 | $86.3 | $35.87 |
| Total cash flows from operations | -$272.16 | $380.35 | -$181.75 | $222.73 |
| Investing activities | ||||
| Capital expenditures | -$25.58 | -$29.01 | -$25.89 | -$14.02 |
| Investments | $602.76 | -$197.51 | -$748.63 | -$329.45 |
| Total cash flows from investing | $577.19 | -$226.52 | -$774.51 | -$344.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.96 | $1.3 | $1407.1 | $19.3 |
| Net borrowings | $297.96 | -$166.17 | $142.16 | |
| Total cash flows from financing | $6.45 | $301.11 | $1238.71 | $611.71 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $311.47 | $454.94 | $282.45 | $489.73 |
News
Fundamentals
| Market cap | $4.03B |
|---|---|
| Enterprise value | $2.46B |
| Shares outstanding | 229.07M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 5.02 |
| Book/Share | 3.50 |
| Cash/Share | 8.16 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 3.48 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.26 |
| Quick ratio | 1.26 |